Subject(s)

Angiotensin-Converting Enzyme 2/antagonists & inhibitors , Antiviral Agents , Coronavirus Infections/drug therapy , Coronavirus/drug effects , Receptors, Virus , Angiotensin II Type 1 Receptor Blockers/chemical synthesis , Angiotensin II Type 1 Receptor Blockers/chemistry , Angiotensin II Type 1 Receptor Blockers/isolation & purification , Angiotensin II Type 1 Receptor Blockers/therapeutic use , Angiotensin-Converting Enzyme 2/physiology , Angiotensin-Converting Enzyme Inhibitors/chemical synthesis , Angiotensin-Converting Enzyme Inhibitors/chemistry , Angiotensin-Converting Enzyme Inhibitors/isolation & purification , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Antiviral Agents/chemical synthesis , Antiviral Agents/chemistry , Antiviral Agents/isolation & purification , Antiviral Agents/therapeutic use , COVID-19/immunology , COVID-19/virology , Coronavirus/physiology , Humans , Immunity/drug effects , Immunity/physiology , Middle East Respiratory Syndrome Coronavirus/drug effects , Middle East Respiratory Syndrome Coronavirus/physiology , Receptor, Angiotensin, Type 1/physiology , Receptors, Virus/antagonists & inhibitors , Receptors, Virus/drug effects , Receptors, Virus/physiology , Renin-Angiotensin System/drug effects , Renin-Angiotensin System/physiology , COVID-19 Drug Treatment